Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-11-19 | Arcutis Biotherapeutics, Inc. | Matsuda Masaru
(See Remarks) |
S | Common Stock | D | 1775 | $9.68 - $9.68 | $17,190 |
| 2024-11-18 | Arcutis Biotherapeutics, Inc. | Matsuda Masaru
(See Remarks) |
A | Common Stock | A | 4875 | $0.00 - $0.00 | $0 |
| 2024-11-14 | Arcutis Biotherapeutics, Inc. | Burnett Patrick
(See Remarks) |
S | Common Stock | D | 69226 | $10.03 - $10.29 | $712,619 |
| 2024-11-14 | Arcutis Biotherapeutics, Inc. | Burnett Patrick
(See Remarks) |
M | Common Stock | A | 18477 | $0.00 - $0.00 | $0 |
| 2024-11-11 | Arcutis Biotherapeutics, Inc. | Curran Terrie
(Director) |
S | Common Stock | D | 8687 | $10.85 - $10.85 | $94,238 |
| 2024-11-04 | Arcutis Biotherapeutics, Inc. | Matsuda Masaru
(See Remarks) |
S | Common Stock | D | 5015 | $8.68 - $8.68 | $43,551 |
| 2024-11-04 | Arcutis Biotherapeutics, Inc. | Watanabe Todd Fra...
(See Remarks) |
S | Common Stock | D | 13871 | $8.68 - $8.68 | $120,458 |
| 2024-11-01 | Arcutis Biotherapeutics, Inc. | Welgus Howard G.
(Director) |
S | Common Stock | D | 10000 | $8.65 - $8.65 | $86,541 |
| 2024-11-04 | Arcutis Biotherapeutics, Inc. | Burnett Patrick
(See Remarks) |
S | Common Stock | D | 15441 | $8.68 - $8.68 | $134,092 |
| 2024-10-01 | Arcutis Biotherapeutics, Inc. | Welgus Howard G.
(Director) |
S | Common Stock | D | 10000 | $9.26 - $9.26 | $92,616 |
| 2024-10-02 | Arcutis Biotherapeutics, Inc. | Edwards Larry Todd
(SVP Chief Commercial Officer) |
S | Common Stock | D | 3725 | $10.01 - $10.01 | $37,295 |
| 2024-09-24 | Arcutis Biotherapeutics, Inc. | Topper David Joseph
(Chief Financial Officer) |
S | Common Stock | D | 11626 | $9.48 - $9.48 | $110,264 |
| 2024-09-21 | Arcutis Biotherapeutics, Inc. | Topper David Joseph
(Chief Financial Officer) |
A | Common Stock | A | 60000 | $0.00 - $0.00 | $0 |
| 2024-08-19 | Arcutis Biotherapeutics, Inc. | Burnett Patrick
(See Remarks) |
S | Common Stock | D | 1728 | $8.29 - $8.29 | $14,318 |
| 2024-08-02 | Arcutis Biotherapeutics, Inc. | Matsuda Masaru
(See Remarks) |
S | Common Stock | D | 5220 | $9.02 - $9.02 | $47,064 |
| 2024-08-02 | Arcutis Biotherapeutics, Inc. | Burnett Patrick
(See Remarks) |
S | Common Stock | D | 13206 | $9.02 - $9.02 | $119,106 |
| 2024-08-02 | Arcutis Biotherapeutics, Inc. | Watanabe Todd Fra...
(See Remarks) |
S | Common Stock | D | 14487 | $9.02 - $9.02 | $130,648 |
| 2024-08-01 | Arcutis Biotherapeutics, Inc. | Welgus Howard G.
(Director) |
S | Common Stock | D | 10000 | $9.87 - $9.87 | $98,695 |
| 2024-08-01 | Arcutis Biotherapeutics, Inc. | Welgus Howard G.
(Director) |
M | Common Stock | A | 6614 | $1.68 - $1.68 | $11,115 |
| 2024-07-01 | Arcutis Biotherapeutics, Inc. | Welgus Howard G.
(Director) |
S | Common Stock | D | 10000 | $9.31 - $9.31 | $93,141 |
| 2024-07-01 | Arcutis Biotherapeutics, Inc. | Welgus Howard G.
(Director) |
M | Common Stock | A | 10000 | $1.68 - $1.68 | $16,805 |
| 2024-05-28 | Arcutis Biotherapeutics, Inc. | Matsuda Masaru
(See Remark) |
S | Common Stock | D | 1775 | $9.01 - $9.01 | $15,988 |
| 2024-05-27 | Arcutis Biotherapeutics, Inc. | Matsuda Masaru
(See Remark) |
A | Common Stock | A | 4875 | $0.00 - $0.00 | $0 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |